Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | The expanding role of PSMA ligands

Shankar Siva • 13 Feb 2020
GU Cancers 2020
General Genitourinary Cancer Kidney Cancer

Shankar Siva, PhD, MBBS, FRANZCR, Peter MacCallum Cancer Centre, Melbourne, Australia, discusses the growing role of PSMA ligands for both the imaging and treatment of cancer, specifically kidney cancer. This interview took place at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

More from Shankar Siva

0:59
Unmet needs for radiotherapy in RCC
Shankar Siva • 17 Feb 2023
0:48
Combining radiotherapy and IO for patients with oligometastatic RCC
Shankar Siva • 17 Feb 2023
1:22
Using SBRT to delay systemic therapy for patients with oligometastatic RCC
Shankar Siva • 17 Feb 2023
1:18
Using radiotherapy to manage oligometastatic kidney cancer
Shankar Siva • 17 Feb 2023

Related Videos

2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
3:07
Serum thymidine kinase 1 as a predicative biomarker in prostate cancer
Teemu Murtola • 9 Apr 2024
0:57
Real-world outcomes of 177Lu-PSMA-617 in mCRPC
Hannah McManus • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals